Connection

Gregory Poland to Humans

Back to Details
This is a "connection" page, showing publications Gregory Poland has written about Humans.
Gregory Poland
Connection Strength
0.273
Humans
  1. Antibody Dynamics, Seroreversion, and Persistence After Severe Acute Respiratory Syndrome Coronavirus 2: Another Answer. Clin Infect Dis. 2021 12 16; 73(12):2163-2165.
    View in: PubMed
    Score: 0.008
  2. Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination. Vaccine. 2021 09 15; 39(39):5666-5672.
    View in: PubMed
    Score: 0.008
  3. The need for broadly protective COVID-19 vaccines: Beyond S-only approaches. Vaccine. 2021 07 13; 39(31):4239-4241.
    View in: PubMed
    Score: 0.008
  4. Readability of Participant Informed Consent Forms and Informational Documents: From Phase 3 COVID-19 Vaccine Clinical Trials in the United States. Mayo Clin Proc. 2021 08; 96(8):2095-2101.
    View in: PubMed
    Score: 0.008
  5. Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects. PLoS One. 2021; 16(6):e0252198.
    View in: PubMed
    Score: 0.008
  6. The development of COVID-19 vaccines in the United States: Why and how so fast? Vaccine. 2021 04 28; 39(18):2491-2495.
    View in: PubMed
    Score: 0.007
  7. Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster. Lancet. 2021 03 06; 397(10277):854-855.
    View in: PubMed
    Score: 0.007
  8. Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design. Vaccine. 2021 03 12; 39(11):1547-1550.
    View in: PubMed
    Score: 0.007
  9. Vaccines, masks, distancing and credibility: An urgent warning for pandemic management. Vaccine. 2021 02 22; 39(8):1173-1174.
    View in: PubMed
    Score: 0.007
  10. The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? Vaccine. 2021 02 22; 39(8):1175-1177.
    View in: PubMed
    Score: 0.007
  11. Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy. Vaccine. 2021 01 15; 39(3):457-459.
    View in: PubMed
    Score: 0.007
  12. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited. J Infect Dis. 2020 Nov 09; 222(11):1776-1779.
    View in: PubMed
    Score: 0.007
  13. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet. 2020 11 14; 396(10262):1595-1606.
    View in: PubMed
    Score: 0.007
  14. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Sci Rep. 2020 08 25; 10(1):14179.
    View in: PubMed
    Score: 0.007
  15. SARS-CoV-2 Vaccine Development: Current Status. Mayo Clin Proc. 2020 10; 95(10):2172-2188.
    View in: PubMed
    Score: 0.007
  16. SARS-CoV-2 Infections: An ACE in the Hole and Systems Biology Studies-a Research Agenda. Mayo Clin Proc. 2020 09; 95(9):1838-1841.
    View in: PubMed
    Score: 0.007
  17. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Vaccine. 2020 06 02; 38(27):4219-4220.
    View in: PubMed
    Score: 0.007
  18. Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients. Infect Control Hosp Epidemiol. 2020 Jul; 41(7):862-864.
    View in: PubMed
    Score: 0.007
  19. SARS-CoV-2: a time for clear and immediate action. Lancet Infect Dis. 2020 05; 20(5):531-532.
    View in: PubMed
    Score: 0.007
  20. Another coronavirus, another epidemic, another warning. Vaccine. 2020 02 28; 38(10):v-vi.
    View in: PubMed
    Score: 0.007
  21. Preserving Civility in Vaccine Policy Discourse: A Way Forward. JAMA. 2019 07 16; 322(3):209-210.
    View in: PubMed
    Score: 0.007
  22. The 2019 immunization schedules for children, adolescents and adults. What's New? Vaccine. 2019 06 06; 37(26):3379-3380.
    View in: PubMed
    Score: 0.007
  23. Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation. Vaccine. 2019 04 10; 37(16):2167-2170.
    View in: PubMed
    Score: 0.007
  24. Strategies to maximize influenza vaccine impact in older adults. Vaccine. 2018 09 25; 36(40):5940-5948.
    View in: PubMed
    Score: 0.006
  25. Immunization education for internal medicine residents: A cluster-randomized controlled trial. Vaccine. 2018 03 27; 36(14):1823-1829.
    View in: PubMed
    Score: 0.006
  26. Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination. J Infect Dis. 2018 01 30; 217(4):560-566.
    View in: PubMed
    Score: 0.006
  27. Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination. PLoS One. 2018; 13(1):e0191812.
    View in: PubMed
    Score: 0.006
  28. Development of vaccines against Zika virus. Lancet Infect Dis. 2018 07; 18(7):e211-e219.
    View in: PubMed
    Score: 0.006
  29. Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering. Sci Rep. 2018 01 15; 8(1):739.
    View in: PubMed
    Score: 0.006
  30. Detection and Quantification of Influenza A/H1N1 Virus-Specific Memory B Cells in Human PBMCs Using ELISpot Assay. Methods Mol Biol. 2018; 1808:221-236.
    View in: PubMed
    Score: 0.006
  31. Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology. PLoS One. 2017; 12(11):e0188149.
    View in: PubMed
    Score: 0.006
  32. Vaccinology in the 21st century-The 10th Annual Vaccine Congress. Vaccine. 2017 08 16; 35(35 Pt A):4451-4452.
    View in: PubMed
    Score: 0.006
  33. Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. Hum Genet. 2017 04; 136(4):421-435.
    View in: PubMed
    Score: 0.006
  34. Heritability of vaccine-induced measles neutralizing antibody titers. Vaccine. 2017 03 07; 35(10):1390-1394.
    View in: PubMed
    Score: 0.006
  35. A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses. PLoS One. 2017; 12(2):e0171261.
    View in: PubMed
    Score: 0.006
  36. Writing a scientific paper-A brief guide for new investigators. Vaccine. 2017 02 01; 35(5):722-728.
    View in: PubMed
    Score: 0.006
  37. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. PLoS One. 2014; 9(6):e99997.
    View in: PubMed
    Score: 0.005
  38. Perspective: Elimination round. Nature. 2014 Mar 06; 507(7490):S16.
    View in: PubMed
    Score: 0.005
  39. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc. 2008 Jan; 83(1):77-84.
    View in: PubMed
    Score: 0.003
  40. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine. 2004 May 07; 22(15-16):1914-20.
    View in: PubMed
    Score: 0.002
  41. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities. Lancet Infect Dis. 2021 11; 21(11):e342-e347.
    View in: PubMed
    Score: 0.002
  42. Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study. Vaccine. 2021 05 06; 39(19):2605-2607.
    View in: PubMed
    Score: 0.002
  43. Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race. J Pediatr. 2021 02; 229:313-314.
    View in: PubMed
    Score: 0.002
  44. The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. 2021 09 24; 39(40):6004-6012.
    View in: PubMed
    Score: 0.002
  45. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev. 2020 07; 296(1):205-219.
    View in: PubMed
    Score: 0.002
  46. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine. 2021 08 31; 39(37):5240-5250.
    View in: PubMed
    Score: 0.002
  47. Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives. Vaccine. 2018 10 01; 36(41):6043-6052.
    View in: PubMed
    Score: 0.002
  48. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine. 2018 02 08; 36(7):921-931.
    View in: PubMed
    Score: 0.002
  49. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S126-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.